Potential role of somatostatin analogues in the treatment of cancer
- 1 August 1987
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 17 (4) , 281-287
- https://doi.org/10.1111/j.1365-2362.1987.tb02188.x
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Somatostatin binding sites in human leptomeninxNeuroscience Letters, 1986
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- Neuropeptides in gliomas: identification of somatostatin 14 in a medulloblastoma.Journal of Neurology, Neurosurgery & Psychiatry, 1986
- Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1985
- Effect of a Long-Acting Somatostatin Analogue (SMS 201–995) in a Patient with Pancreatic CholeraNew England Journal of Medicine, 1985
- SomatostatinNew England Journal of Medicine, 1983
- SomatostatinNew England Journal of Medicine, 1983
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Polypeptide growth factors: Some structural and mechanistic considerationsJournal of Supramolecular Structure, 1980
- Somatostatin inhibits the mitogenic effect of thyroliberinCellular and Molecular Life Sciences, 1978